Related Experiment Video

Updated: Oct 23, 2026

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome
08:49

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome

Published on: September 23, 2015

Lack of serotonin neurotoxicity after intraraphe microinjection of (+)-3,4-methylenedioxymethamphetamine (MDMA)

J M Paris1, K A Cunningham

  • 1Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston 77550.

Brain Research Bulletin
|January 1, 1992
PubMed

Insights

A single dose of 3,4-methylenedioxymethamphetamine (MDMA) directly injected into the dorsal or median raphe nuclei did not cause neurotoxicity to serotonin (5-HT) systems. Further research is needed to determine effects of multiple MDMA injections.

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • Systemic 3,4-methylenedioxymethamphetamine (MDMA) administration depletes serotonin (5-HT) and its metabolite 5-hydroxyindoleacetic acid (5-HIAA).
  • MDMA neurotoxicity affects dorsal raphe (DR) 5-HT neurons but spares median raphe (MR) 5-HT neurons.
  • Previous studies indicate MDMA's differential impact on distinct 5-HT neuronal populations.

Purpose of the Study:

  • To investigate whether direct microinjection of MDMA into the DR or MR induces differential neurotoxicity.
  • To assess the impact of localized MDMA administration on 5-HT levels and neuronal integrity.

Main Methods:

  • Rats received stereotaxic microinjections of (+)MDMA or vehicle into the DR or MR.
  • Brain tissue was analyzed for 5-HT and catecholamine content using High-Performance Liquid Chromatography (HPLC).
  • 5-HT immunocytochemistry was performed on raphe sections to evaluate neuronal damage.

Main Results:

  • No significant changes in monoamine or metabolite concentrations were observed in the hippocampus and striatum following intra-DR or -MR (+)MDMA injections.
  • 5-HT immunocytochemistry revealed no apparent neurotoxicity in the raphe nuclei.
  • A single localized MDMA administration did not induce neurotoxicity in the studied 5-HT neuronal systems.

Conclusions:

  • A single cerebral injection of (+)MDMA does not produce neurotoxicity to 5-HT neuronal systems originating in the raphe.
  • The neurotoxic effects of multiple MDMA injections into these raphe nuclei remain undetermined.
  • Localized administration highlights the need for further investigation into dose-dependent and repeated exposure effects.

More Related Videos

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration09:16

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

Neurotoxicity Assessment in Adult Danio rerio using a Battery of Behavioral Tests in a Single Tank08:36

Neurotoxicity Assessment in Adult Danio rerio using a Battery of Behavioral Tests in a Single Tank

Published on: November 3, 2023

Related Concept Videos

Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
CNS Stimulants: Psychedelic Agents01:22

CNS Stimulants: Psychedelic Agents

Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...